A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/335 (2006.01) A61K 31/555 (2006.01) A61K 33/04 (2006.01) A61K 33/24 (2006.01)
Patent
CA 2206567
There are provided compositions for, and a method of, treating malignancies which comprise effective amounts of a novel combined therapy comprising a taxane compound, e.g., paclitaxel, and a tellurium or selenium compound, e.g., ammonium trichloro(dioxoethylene-O,O-tellurate), and administering the respective compounds simultaneously or separately.
Compositions et procédé permettant de traiter des tumeurs malignes. Les compositions renferment une quantité efficace d'un nouveau produit thérapeutique comprenant un composé du taxane, par exemple du paclitaxel, et un composé du tellure ou du sélénium, par exemple du trichloro(dioxoéthylène-0,0-tellurate) d'ammonium. Administration simultanée ou distincte des divers composés.
Albeck Michael
Bruckner Howard B.
Mettinger Karl L.
Sredni Benjamin
Whisnant John
Baker Norton Pharmaceuticals Inc.
Moffat & Co.
LandOfFree
Method and composition for reducing tumor development with a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and composition for reducing tumor development with a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for reducing tumor development with a... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1868377